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Glucose, the main energy substrate used in the CNS,
is continuously supplied by the periphery. Gluta-
mate, the major excitatory neurotransmitter, is fore-
seen as a complementary energy contributor in the
brain. In particular, astrocytes actively take up gluta-
mate and may use it through oxidative glutamate de-
hydrogenase (GDH) activity. Here, we investigated
the significance of glutamate as energy substrate
for the brain. Upon glutamate exposure, astrocytes
generated ATP in a GDH-dependent way. The
observed lack of glutamate oxidation in brain-spe-
cific GDH null CnsGlud1/mice resulted in a central
energy-deprivation state with increased ADP/ATP
ratios and phospho-AMPK in the hypothalamus.
This induced changes in the autonomous nervous
system balance, with increased sympathetic activity
promoting hepatic glucose production and mobili-
zation of substrates reshaping peripheral energy
stores. Our data reveal the importance of glutamate
as necessary energy substrate for the brain and the
role of central GDH in the regulation of whole-body
energy homeostasis.
INTRODUCTION
In the CNS, the role of glutamate as a signaling molecule for
excitatory transmission acting through neuronal receptors is
well described (Baudry and Lynch, 1979). Furthermore, gluta-
mate is a key metabolite for both nitrogen and energy meta-
bolism in the brain (Escartin et al., 2006). Disturbances in
central glutamate homeostasis are associated with neurolog-
ical disorders such as schizophrenia and epilepsy (Gaisler-Sal-
omon et al., 2009; Gordon, 2010; Harris et al., 2009; Meldrum,
1994). Upon glutamatergic transmission, intersynaptic gluta-
mate clearance is achieved mostly by glial cells, namely astro-Ccytes (Bak et al., 2006). Such active uptake prevents gluta-
mate accumulation in the extracellular space and associated
toxicity. Following its uptake, glutamate may be amidated to
glutamine and then recycled back to neurons (i.e., the gluta-
mate-glutamine cycle). Alternatively, glutamate may be used
by astrocytes as an energy substrate via deamination to a-ke-
toglutarate before further oxidation in the tricarboxylic acid
(TCA) cycle, thereby promoting ATP generation (McKenna
et al., 1996; Yu et al., 1982). In vitro, glutamate has been
shown to be oxidized in a variety of different brain tissue prep-
arations (Zielke et al., 2009). In vivo, the contribution of gluta-
mate as a metabolic substrate for energy production within the
brain is still uncertain (Magistretti et al., 1999; Peters et al.,
2004; Zielke et al., 2009).
Because of substrate selectivity across the blood-brain bar-
rier, glucose is themain energy source delivered by the periphery
to the CNS (Vannucci et al., 1997), and astrocytes phosphorylate
approximately half of this plasma-derived glucose (Nehlig, 2004).
Subsequent to its phosphorylation, glucose is metabolized
through glycolysis, and then glucose carbons may follow path-
ways other than the TCA cycle (Verleysdonk and Hamprecht,
2000). In addition, glucose is an important modulator of central
regulation of the peripheral energy balance. Specific hypo-
thalamic and brainstem neurons increase their firing rate in
response to high or low glucose concentrations (Karnani and
Burdakov, 2011; Yang et al., 2004). Current models propose
that hypothalamic nutrient-sensing mechanisms regulate food
intake, hormonal responses, and hepatic glucose production in
order to maintain energy homeostasis (Blouet and Schwartz,
2010; Lam et al., 2009).
In the brain, glutamate is predominantly derived from glucose
catabolism and subsequent TCA cycle metabolism (Gruetter
et al., 1994; Hertz et al., 2007). The latter provides substrates
for glutamate dehydrogenase (GDH), an essential enzyme con-
necting glucose and glutamate metabolism (Karaca et al.,
2011). This mitochondrial enzyme catalyzes the reversible reac-
tion a-ketoglutarate + NH3 + NADH4 glutamate + NAD
+ (San-
ner, 1975). GDH is a homohexamer (Hucho et al., 1975) encoded
by the well-conserved 45-kb GLUD1 gene (Michaelidis et al.,ell Reports 13, 365–375, October 13, 2015 ª2015 The Authors 365
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Figure 1. Lack of GDH in CnsGlud1/
Brains Impairs Glutamate-Induced Energy
Generation
(A) Representative recordings of cellular ATP in
control Glud1lox/lox (left panel) and GDH null
CnsGlud1/ isolated astrocytes (right panel)
expressing the FRET-based ATP indicator.
Cultured astrocytes were stimulated with 500 mM
glutamate (Glu) followed by 6 mM glucose
(Glc) before mitochondrial uncoupling with 1 mM
FCCP.
(B) Oxygen consumption in mitochondria isolated
from Glud1lox/lox control and CnsGlud1/ brains
in response to 10 mM glutamate (Glu) (left panel)
and 5 mM succinate (Succ) (right panel) in the
presence or absence of 100 mM ADP (n = 5). See
also Figure S1.
(C) Hypothalamic ADP/ATP ratio from Glud1lox/lox
control and CnsGlud1/ mice (n = 4–5).
(D) Immunoblotting on hypothalamic extracts from
Glud1lox/lox control and CnsGlud1/ mice
showing phospho-AMPKa (P-AMPKa) relative to
total AMPKa levels (n = 6).
All values are means ± SEM. *p < 0.05; **p < 0.01;
***p < 0.001.1993). In the CNS, GDH is predominantly expressed in astro-
cytes (Mastorodemos et al., 2005), an alternative pathway to
glutamate-glutamine cycling that provides neurotransmitter pre-
cursors for glutamatergic neurons. Related to the high capacity
for glutamate uptake by astrocytes, GDH is a putative regulator
of brain energy homeostasis through the glutamate oxidative
pathway.
The present study investigated the role of GDH in the selec-
tivity of energy substrates within the CNS, in particular the
recycling of the neurotransmitter glutamate versus glucose
provided by the periphery. Analysis of brain-specific GDH null
CnsGlud1/ mice revealed a major impact on peripheral en-
ergy partitioning compatible with the ‘‘selfish brain’’ paradigm
(Peters et al., 2004). According to this model, the brain may re-
route energy substrates at the expense of peripheral tissues
whenever necessary. The lack of GDH-dependent glutamate
oxidation in CnsGlud1/ brains established an energy-depri-
vation state despite normoglycemia. This induced changes
in the autonomous nervous system balance, favoring the
mobilization of glucose and ketone bodies from the periphery
through AMPK-dependent mechanisms. This study reveals
the role of central GDH in the regulation of whole-body energy
homeostasis.366 Cell Reports 13, 365–375, October 13, 2015 ª2015 The AuthorsRESULTS
Brain-Specific Deletion of GDH
Leads to Central Energy Deficiency
Brain-specific GDH knockout
(CnsGlud1/) mice were generated by
crossing Glud1lox/lox with Nestin-Cre
mice (Frigerio et al., 2012). We previously
reported that the lack of GDH in the CNS
modifies the metabolic fate of glutamatewithout altering synaptic transmission in basal conditions
(Frigerio et al., 2012).
Glutamate may be catabolized by GDH through oxidative
deamination fueling the TCA cycle and, as a consequence, acti-
vation of the respiratory chain potentially generating ATP. In or-
der to characterize GDH-dependent energy substrates of the
CNS, cellular ATP was measured in response to glutamate and
glucose. When Glud1lox/lox control astrocytes were stimulated
with glutamate, ATP levels were transiently lowered for 1 min,
possibly due to energy-consuming glutamate uptake (Danbolt,
2001; McKenna, 2013), before sustained ATP elevation (Fig-
ure 1A). In GDH null CnsGlud1/ astrocytes, ATP levels failed
to increase in response to glutamate, as only a continuous
drop was observed (Figure 1A). However, both Glud1lox/lox con-
trol and CnsGlud1/ astrocytes were responsive to glucose
stimulation (Figure 1A). Oxygen consumption was induced in
control brain mitochondria upon glutamate stimulation and was
further enhanced by the addition of ADP (Figure 1B). On the con-
trary, glutamate did not increase respiration of CnsGlud1/
brain mitochondria (Figure 1B). In order to test GDH-indepen-
dent mitochondrial respiration, succinate was used as a sub-
strate and induced similar oxygen consumption in control and
CnsGlud1/ brain mitochondria (Figure 1B). As an additional
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Figure 2. Lack of GDH in CnsGlud1/
Brains Increases Glucose Utilization
(A) Intra-brain metabolite concentrations measured
by NMR (1H-MRS) on living Glud1lox/lox control and
CnsGlud1/ mice (n = 9–10). The blue square on
the slice image represents the volume of interest
that was analyzed; Mac, macromolecules; Ala,
alanine; Asp, aspartate; PCho, phosphorylcholine;
Glc, glucose; Cr, creatine; PCr, phosphocreatine;
GABA, g-aminobutyric acid; Gln, glutamine; Glu,
glutamate; GSH, glutathion; Gly, glycine; Ins, myo-
inositol; Lac, lactate; NAA, N-acetylaspartate;
Scyllo, scyllo inositol; Tau, taurine; Asc, ascorbate;
NAAG, N-acetylaspartylglutamate; GPC, glycero-
phosphocholine; and PE, phosphoethanolamine.
(B) Brain glucose uptake of Glud1lox/lox control and
CnsGlud1/ mice following intravenous [14C]-2-
deoxyglucose ([14C]-2-DG) administration (n = 5–6).
(C) Cellular ATP levels of Glud1lox/lox control and
CnsGlud1/ astrocytes expressing luciferase-
based ATP reporter. Cultured astrocytes were
stimulated with 6 mM glucose (Glc) before mito-
chondrial poisoning with 2mMNaN3 (n = 9). Values
are normalized to basal levels without mitochon-
drial contribution (+NaN3).
(D and E) 13C-glutamate percent enrichment (D)
and total amount (nmol/mg protein) (E) obtained
from [U-13C]glucose incubation of astrocytes iso-
lated from Glud1lox/lox control and CnsGlud1/
mice (n = 5–7).
All values are means ± SEM. *p < 0.05; ***p <
0.001.control of tissue specificity, we analyzed mitochondria isolated
from liver, notably rich in GDH. Liver GDH activity was compara-
ble between Glud1lox/lox control and CnsGlud1/ mice, and
respiration was similarly induced by glutamate and succinate
in CnsGlud1/ liver mitochondria compared to controls (Figures
S1A and S1B). These data show that astrocytes can generate
ATP upon glutamate stimulation in a GDH-dependent manner.
In the absence of GDH-dependent glutamate oxidation,
CnsGlud1/ animals showed increased hypothalamic ADP to
ATP ratio (+65%, p < 0.05; Figure 1C). This correlated with
increased hypothalamic levels of phospho-AMPK (P-AMPK)
(+50%, p < 0.01), a major sensor of cellular energy deprivation
(Figure 1D).
As revealed by nuclear magnetic resonance (NMR) measure-
ments in living non-fasted animals (Figure 2A), intra-brain gluta-
mine concentrations were higher in knockout mice than control
mice (+23%, p < 0.05), in accordance with impaired glutamate
consumption (Frigerio et al., 2012).Conversely, brainglucosecon-
centrationswere lower inCnsGlud1/mice thancontrols (47%,
p < 0.05) in conditions of peripheral normoglycemia (Figures 2A).
Of note, the lower brain glucose observed in knockout mice re-Cell Reports 13, 365–375,mained in the range associated with pe-
ripheral euglycemia (i.e., brain glucose
0.8–2.6 mmol/g and plasma glucose 4.5–
10 mM; Choi et al., 2001). Glucose uptake
was higher in CnsGlud1/ brains than in
controls (+54%, p < 0.05; Figures 2B).Astrocyte cultures isolated fromCnsGlud1/ animals had slightly
lower basal ATP levels when glucose deprived. However, they
robustly generated ATP upon glucose stimulation, exhibiting
compensatory glucose response compared with controls (Fig-
ure 2C). The increased glucose consumption in the brain of
CnsGlud1/ mice was further evidenced by an increased incor-
poration of 13C from 13C-glucose into the glutamate pool. The
13Cenrichmentwasmaintained, although the total cellular content
of glutamate (nmol/mg protein) was elevated by 50% (Figures 2D
and 2E). The 13C-labeling of glutamate reflects glucose meta-
bolism (i.e., acetyl-coenzyme A enrichment and TCA cycle meta-
bolism) due to the high activity of aspartate aminotransferase
(Mason et al., 1995). Altogether, these data show central gluta-
mate-dependent energy deficit in CnsGlud1/ mice, compen-
sated by increased glucose usage in the brain.
Lack of Brain GDH Reshapes Body Composition and
Alters Peripheral Glucose Homeostasis
Brain energy homeostasis is modulated by the cross-talks be-
tween CNS and metabolically active peripheral tissues. How-
ever, it primarily relies on the provision of exploitable substratesOctober 13, 2015 ª2015 The Authors 367
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Brains Modifies Lean/Fat Mass Distribution
and Alters Glucose Homeostasis
(A) Food intake recorded over a representative
24-hr period. See also Figure S2.
(B) Body composition showing lean and fat
mass distribution in Glud1lox/lox Control and
CnsGlud1/ mice measured by EchoMRI (n =
17–20). See also Figure S3.
(C) Plasma leptin levels in fed and overnight-fasting
Glud1lox/lox control and CnsGlud1/ mice (n = 7).
(D) Plasma glucose levels in fed and overnight-
fasting Glud1lox/lox control and CnsGlud1/ mice
(n = 9–10). See also Figure S3.
(E) Glucose tolerance test (1 g/kg) in Glud1lox/lox
control and CnsGlud1/ mice (left panel) and its
quantification as AUC (right panel) (n = 12–13).
AUC, area under the curve.
All values are means ± SEM. *p < 0.05; **p < 0.01;
***p < 0.001.delivered from the periphery, which is influenced by the balance
of food intake and energy expenditure. CnsGlud1/ mice
did not modify their feeding behavior to compensate for
the loss of central glutamate-derived energy (Figures 3A and
S2A). However, as assessed by quantitative magnetic reso-
nance (Figure 3B), their body composition was reshaped with
increased fat mass (+50%, p < 0.001) and decreased lean
mass (7%, p < 0.001), without affecting total body weight.
Increased plasma leptin levels in CnsGlud1/ animals, re-
flecting the extent of fat depots, paralleled adipose tissue
mass (Figure 3C). Although we observed lower spontaneous
locomotor activity during the daytime in CnsGlud1/mice (Fig-
ure S2B), the VO2 and VCO2 were not significantly different
compared to control mice (Figures S2C and S2D). The calcu-
lated VCO2/VO2 revealed no difference in respiratory exchange
ratio (RER) between the two groups (Figures S2E and S2F).
Finally, body heat production and water intake were similar in
CnsGlud1/mice and controls (Figures S2G and S2H). There-368 Cell Reports 13, 365–375, October 13, 2015 ª2015 The Authorsfore, analyzed at the whole-body level,
CnsGlud1/mice exhibited comparable
metabolic rates with similar proportions
of carbohydrate versus fatty acid oxida-
tion. Normalization of parameters from
metabolic cages (Figure S2) to lean
mass (Figure 3B) resulted in similar
outcome (data not shown). These data
demonstrate that ablation of GDH in the
brain modified energy distribution in the
periphery without affecting food intake
and overall energy expenditure.
Glucose is the main energy substrate
contributed by the periphery to the
CNS. The elevated glucose usage in
CnsGlud1/ brain prompted us to inves-
tigate peripheral glucose homeostasis.
Although the glycemiawas unchanged un-
der fed conditions, fasting CnsGlud1/
mice had lower blood glucose levels thanGlud1lox/lox controls (22%, p < 0.01) (Figure 3D). Glucose toler-
ance tests revealed impaired glucose clearance in CnsGlud1/
animals with an area under the curve (AUC) increased by 57%
(p < 0.01) (Figure 3E). These data show that central energy
perturbation in CnsGlud1/ mice impairs peripheral glucose
homeostasis.
Nestin-Cre Transgene Does Not Contribute to the
Metabolic Phenotype of CnsGlud1/ Mice
To rule out the possibility that the Nestin-Cre transgene used in
the study may have independently contributed to the metabolic
phenotype, we analyzed in parallel transgenic mice carrying only
the Nestin-Cre transgene and their respective Nestin-Cre-nega-
tive littermates. We previously reported that CnsGlud1/ mice
express normal levels of GDH in non-brain tissues such as liver,
kidney, or spleen (Karaca and Maechler, 2014). Additionally, no
differences in body weight (Figure S3A; Karaca and Maechler,
2014), body composition (Figure S3B), and glycemia (Figure S3C)
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B Figure 4. Function of Pancreatic Islet Is Pre-
served in CnsGlud1/ Mice
(A) Representative images of immunohistoche-
mical analyses on pancreas sections from
Glud1lox/lox control and CnsGlud1/ mice co-
stained for insulin (red), glucagon (green), and
nuclei (blue). Scale bar, 20 mm.
(B) Insulin contents of pancreata isolated from
Glud1lox/lox Control and CnsGlud1/ mice (n = 5).
(C) Glucose-stimulated insulin release determined
using in situ pancreatic perfusions on Glud1lox/lox
control and CnsGlud1/ mice. Glucose was
raised from basal 2.8 mM (2.8 Glc) to stimulatory
22.8mM (22.8Glc) (left panel). The insulin secreted
over the stimulatory period is presented as AUC
(right panel) (n = 4–8). AUC, area under the curve.
See also Figure S4.
(D and E) Plasma insulin (D, n = 10) and glucagon
(E, n = 17–22) levels in fed and overnight fasting
Glud1lox/lox Control and CnsGlud1/ mice. See
also Figure S4.
All values are means ± SEM. *p < 0.05; ***p <
0.001.were observed between genotypes, being either Nestin-Cre
negative or Nestin-Cre positive. Accordingly, Nestin-Cre trans-
gene did not contribute to the metabolic phenotype observed
in CnsGlud1/ mice, supporting the use of Glud1lox/lox litter-
mates as a control group, which allows homogenization of the
genetic background.
Pancreatic Islet Function Is Preserved in CnsGlud1/
Mice
Inability to properly regulate glycemia after a glucose load
could be due to altered pancreatic function. Immunohisto-Cell Reports 13, 365–375,chemistry performed on pancreas sec-
tions showed normal islet architecture
when co-stained for insulin and
glucagon (Figure 4A). Pancreatic
insulin content was similar between
Glud1lox/lox control and CnsGlud1/
mice (Figure 4B). We performed
in situ pancreatic perfusions to test
the b cell response in islets maintained
in their native pancreatic environment.
This revealed normal glucose-stimu-
lated insulin secretion when pancreas
of CnsGlud1/ were compared with
those of Glud1lox/lox controls (Fig-
ure 4C). A similar profile was observed
with in vitro perifusion of isolated
islets stimulated with 22.8 mM
glucose (Figure S4A). Finally, circu-
lating insulin, C-peptide, and glucagon
levels did not differ between
CnsGlud1/ and Glud1lox/lox controls,
either in fed or fasting conditions (Fig-
ures 4D, 4E, and S4B). These data
show that the defect in glucose ho-meostasis in CnsGlud1/ mice is not contributed by an
altered pancreatic function.
Hepatic Glucose Production Is Increased in
CnsGlud1/ Mice
Besides the b cell, altered glucose homeostasis could result from
increased endogenous glucose production and/or decreased
glucose uptake by peripheral tissues, in particular muscles
and adipocytes. The glucose turnover rate was assessed using
the hyperinsulinemic-euglycemic clamp technique. The whole-
body glucose utilization rate (GUR) was not different betweenOctober 13, 2015 ª2015 The Authors 369
AC D
B Figure 5. Hepatic Glucose Production Is
Enhanced in CnsGlud1/ Mice
(A) Glucose turnover rate determined by hyper-
insulinemic-euglycemic clamp experiments on
Glud1lox/lox control and CnsGlud1/ mice (n =
7–13). Glucose utilization rate (GUR), glucose
infusion rate (GIR), and endogenous glucose pro-
duction (eGP) are shown here.
(B) Hepatic glucose production assessed by py-
ruvate challenge (2 g/kg) in Glud1lox/lox control and
CnsGlud1/ mice and blood glucose quantifica-
tion by the AUC (n = 11). AUC, area under the
curve.
(C) Hepatic glycogen contents measured in livers
collected from non-fasted Glud1lox/lox control and
CnsGlud1/ mice (n = 7).
(D) Glucose utilization index (GUI) in soleus (Sol),
gastrocnemius (Gast), and tibialis anterior (TLA)
muscles, as well as in subcutaneous (sc) and
visceral (visc) adipose tissues (AT). Measurements
are from clamp experiments onGlud1lox/lox control
and CnsGlud1/ mice upon injection of [14C]-2-
deoxyglucose (n = 6–11).
All values are means ± SEM. *p < 0.05; ***p <
0.001.Glud1lox/lox control and CnsGlud1/ mice (Figure 5A), although
less glucose was needed to maintain euglycemia, as shown by
the decreased glucose infusion rate (GIR) (59%, p < 0.001, Fig-
ure 5A). This observation correlated with increased endogenous
glucose production (eGP) (+121%, p < 0.05) in CnsGlud1/
mice when compared with Glud1lox/lox controls (Figure 5A).
Glucose derived from pyruvate reflects hepatic gluconeogen-
esis. A pyruvate challenge induced higher blood glucose levels
in CnsGlud1/mice than inGlud1lox/lox controls (Figure 5B). He-
patic glycogen concentrations measured both under fed (Fig-
ure 5C) and fasting (not shown) conditions were similar between
groups, indicating that glycogenolysis did not account for the
observed higher glucose production. Measurements of 2-deox-
yglucose uptake during the hyperinsulinemic clamp revealed
lower uptake in mixed gastrocnemius muscle (69%, p <
0.05), while there was no difference in the soleus and tibialis
anterior muscles or subcutaneous and visceral adipose tissues
(Figure 5D). These data show that the increased glucose avail-
ability in CnsGlud1/mice was due to higher liver gluconeogen-
esis and lower muscle glucose uptake.
Energy Substrates Are Mobilized from Peripheral
Tissues in CnsGlud1/ Mice
In conditions of energy scarcity in the CNS, amino acids can be
mobilized from skeletal muscles for hepatic gluconeogenesis
(glucogenic amino acids: Asp, Glu, Ser, Gln, His, Gly Thr, Arg,
Ala, Val, Tyr, Phe, and Ile) and ketogenesis (ketogenic amino
acids: Leu, Tyr, Phe, and Ile). Plasma concentrations of most
amino acids were markedly reduced in both fed and fasting
conditions in CnsGlud1/ mice in comparison with Glud1lox/lox
controlmice, in particular the ketogenic ones (Figure 6A). Accord-
ingly, circulating ketone bodies, in particular b-hydroxybutyrate,
were higher in CnsGlud1/ mice (+49%, p < 0.01; Figure 6B).
Regarding plasma lipids in CnsGlud1/ mice, both free fatty370 Cell Reports 13, 365–375, October 13, 2015 ª2015 The Authorsacids (+36%, p < 0.01) and triglycerides (+56%, p < 0.001)
were elevated in comparison with Glud1lox/lox controls (Figures
6C and 6D). Upon energy need, lipolysis of fat stored as triglycer-
ides in adipose tissues releases free fatty acids used for b-oxida-
tion, ketogenesis, and reformation of triglyceride-rich lipopro-
teins in the liver. Higher expression of hormone sensitive lipase
(HSL) in adipose tissue of CnsGlud1/ mice further confirmed
enhanced lipid turnover in brain GDH null animals (Figure 6E).
These data show that mobilization of energy substrates from pe-
ripheral tissues is increased in CnsGlud1/ mice.
Substrate Mobilization in CnsGlud1/ Mice Is
Orchestrated by the Autonomous Nervous System
Next, hormones responsible for substrates mobilization were
analyzed. Plasma concentrations of corticosterone as well as
those of the pancreatic hormone glucagon remained unchanged
in CnsGlud1/ andGlud1lox/lox control mice (Figures 7A and 4E).
Remarkably, CnsGlud1/ mice exhibited an increase in cate-
cholamine levels (epinephrine, +36%, p < 0.05; norepineph-
rine, +42%, p < 0.05) along with a decrease in plasma pancreatic
polypeptide levels (63%, p < 0.05) compared with Glud1lox/lox
controls (Figures 7B–7D). Catecholamines are stimulated by
the sympathetic nervous system (SNS), while pancreatic poly-
peptide is commonly used as amarker of parasympathetic activ-
ity. Higher global SNS activity in CnsGlud1/ mice was uncov-
ered by in vivo nerve recordings, performed in non-fasted
normoglycemic conditions, showing increased firing rates of
the sympathetic nerve compared to controls (Figures 7E and
7F). To directly test whether SNS outflow onto liver was affected
in CnsGlud1/ mice, we used the synthesis inhibition method
(Brodie et al., 1966) in order to measure the catecholamine turn-
over rate (TR). In the liver of CnsGlud1/ mice, there was a 1.8-
fold increase in basal norepinephrine (NE) concentrations [NE0]
compared to controls. The fractional turnover constant k was
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Figure 6. Increased Peripheral Mobilization
of Energy Substrates in CnsGlud1/ Mice
(A) Concentrations of circulating amino acids
in fed (left panel) and overnight fasting (right
panel) Glud1lox/lox control and CnsGlud1/ mice
measured by high-performance liquid chroma-
tography (n = 16–17).
(B–D) Plasma concentrations of b-hydroxybuty-
rate (B), free fatty acids (C), and triglycerides (D) in
fed and overnight-fasting Glud1lox/lox control and
CnsGlud1/ mice (n = 6–9).
(E) Gene expression of adipose tissue hormone-
sensitive lipase (HSL), normalized to cyclophilin
(n = 4).
All values are means ± SEM. *p < 0.05; **p < 0.01;
***p < 0.001.2.5-fold higher in CnsGlud1/ liver, revealing a net decrease in
NE half-life. TR, a readout of SNS outflow, was 4-fold higher in
CnsGlud1/ mice compared with controls (Figures 7G–7I).
Analysis of mice lacking brain GDH reveals that glutamate-
related central energy deficiency (Figure 1) induces an increased
sympathetic-to-parasympathetic balance, promoting substrate
mobilization from the periphery through the liver (Figure 7).
DISCUSSION
Body energy homeostasis is controlled by complex interactions
between the CNS and peripheral tissues. Although the brain rep-
resents 2% of the body’s weight, it accounts for 20% of basal
energy expenditure (Kety, 1957; Rolfe and Brown, 1997; Sokol-
off, 1960), requiring accurate regulation of substrate supply in
order to ensure its function in various nutritional or pathological
conditions.
Glucose is the essential metabolic fuel for the CNS under
physiological conditions. The brain is highly dependent on
a continuous glucose supply from the periphery because of
its poor capacity to synthesize glucose or store glycogen. In
addition, concentrations of possible alternative substrates
are low under physiological conditions (e.g., ketone bodies)
or their transport across the blood-brain barrier is limitedCell Reports 13, 365–375,(e.g., free fatty acids), thereby mini-
mizing their use in standard conditions.
Glutamate is the most abundant ex-
citatory neurotransmitter and, besides
glucose, may also contribute to sustain
brain energy homeostasis. Accordingly,
glutamate can be oxidized by astrocytes
at higher rate than glucose, 3-hydroxy-
butyrate, glutamine, lactate, or malate
(McKenna, 2012). Following its uptake
by astrocytes, the glutamate fraction
escaping the glutamate-glutamine cycle
can be converted to a-ketoglutarate,
either by transamination reactions or by
NADH-producing oxidation catalyzed by
GDH, an enzyme abundant in astrocytes
(Lovatt et al., 2007; McKenna, 2007; Za-
ganas et al., 2001, 2012). The oxidative catabolism of glutamate
proceeds primarily via GDH in rat astrocytes (McKenna et al.,
1996; Westergaard et al., 1996). The a-ketoglutarate derived
from glutamate activates the TCA cycle, thereby promoting
ATP production by the respiratory chain. According to these
pathways, GDH might play a pivotal role in both energy meta-
bolism and recycling of the main excitatory neurotransmitter
(Karaca et al., 2011), with potential impact on peripheral tissues.
Initial insights into CnsGlud1/ mice showed that the lack of
GDH in the CNS modified the metabolic handling of glutamate
without altering synaptic transmission under basal conditions
(Frigerio et al., 2012). In the present study, we investigated the
metabolic role of brain GDH and the importance of glutamate
as an energy substrate for the CNS. We first observed that con-
trol astrocytes could produce ATP in response to glutamate
stimulation, following a first transient drop contributed by the en-
ergy-consuming uptake process (McKenna, 2013). While their
glucose response was preserved, GDH null astrocytes isolated
from CnsGlud1/ mice were unable to generate ATP upon
glutamate exposure, resulting in continuous and non-compen-
sated ATP consumption. Accordingly, glutamate failed to acti-
vate mitochondria isolated from GDH null brains, whereas the
GDH-independent substrate succinate efficiently induced mito-
chondrial respiration. These data demonstrate that astrocytesOctober 13, 2015 ª2015 The Authors 371
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Figure 7. Increased Sympathetic and
Decreased Parasympathetic Activities in
CnsGlud1/ Mice
(A–D) Plasma concentrations of corticosterone
measured in the late light phase (A), epinephrine
(B) and norepinephrine measured in fasting state
(C), and pancreatic polypeptide measured in fed
state (D) in Glud1lox/lox control and CnsGlud1/
mice (n = 10–16).
(E–I) Sympathetic nervous system activity with
representative recordings of sympathetic activity
inGlud1lox/lox control and CnsGlud1/mice in the
basal fed state (E) and quantification of sympa-
thetic firing activity (F) (n = 7–8). Liver norepi-
nephrine content (G) and turnover rate (H) after
a-MPT injection. (I) Basal liver norepinephrine (NE)
levels (NE0), fractional turnover constants (k), and
turnover rates (TR) (n = 4–6).
All values are means ± SEM. *p < 0.05; **p < 0.01.can efficiently use glutamate for ATP production and that this
process requires GDH. This energy-producing activity was
abrogated in the absence of GDH, showing that transaminases
do not compensate for the lack of GDH-dependent glutamate
oxidation.
Lack of GDH-dependent glutamate oxidation resulted in
increased hypothalamic ADP/ATP ratio and induced P-AMPK,
a cellular energy sensor (Hardie and Carling, 1997). Both uptake
and utilization of glucose were higher in CnsGlud1/ brains
compared to controls. Accordingly, lower brain glucose concen-
trations, remaining within the physiological range (Choi et al.,
2001), were measured in CnsGlud1/ brains along with periph-
eral normoglycemia. Astrocytes from CnsGlud1/ mice effi-
ciently generated ATP upon glucose stimulation, exhibiting
even compensatory glucose responses compared with controls.
Our data show that the deletion of GDH in the CNS subtracted
glutamate as a source of energy, inducing compensatory usage
of glucose by the brain.
The modified brain energy homeostasis in CnsGlud1/ mice
did not impact on global energy exchanges in terms of food372 Cell Reports 13, 365–375, October 13, 2015 ª2015 The Authorsintake and calorie expenditure. However,
body composition was reshaped with
increased fat mass and decreased lean
mass, without net changes in body
weight. In the periphery, CnsGlud1/
mice exhibited lower glycemia under fast-
ing conditions and glucose intolerance
following a glucose load. Altered pan-
creatic function did not contribute to
impaired peripheral glucose homeosta-
sis, as glucose-stimulated insulin secre-
tion was preserved in CnsGlud1/
animals. Hyperinsulinemic-euglycemic
clamp studies showed that glucose
availability in CnsGlud1/ mice was
increased by both higher liver gluconeo-
genesis and lower muscle glucose up-
take.We also observed increased plasmalevels of ketone bodies, an alternative energy source for the
CNS under conditions such as scarcity. Upregulation of the
hormone-sensitive lipase in adipose tissues favored recruitment
of fatty acids necessary for hepatic ketogenesis. Moreover,
CnsGlud1/mice presented partial depletion of circulating glu-
cogenic and ketogenic amino acids. These findings suggest
metabolic adaptation of CnsGlud1/ mice, with increased fat
and muscle turnover providing energy substrates for the brain
through liver function.
Maintenance of energy substrate homeostasis is crucial for
the CNS and relies mainly on glucose provision from the periph-
ery but also on recycled glutamate, as shown in the present
study. The liver is the major source of glucose production. He-
patic glycogenolysis and gluconeogenesis promote glucose
release into the bloodstream and availability for glucose-depen-
dent tissues. In mammalian organisms, one of the most alarming
states is a lowering of brain-compatible energy substrates,
which induces counter-regulatory elevation of the sympathetic
tone and in turn increases circulating levels of energy-recruiting
hormones such as glucagon, adrenaline, and cortisol.
There are different mechanisms for CNS-mediated hormonal
regulation of hepatic glucose production; among them, central
AMPK plays a major role. Hypothalamic AMPK has been impli-
cated in the regulation of food intake (Andersson et al., 2004;
Kim et al., 2004a, 2004b; Lee et al., 2005; Minokoshi et al.,
2004) and is activated in response to fasting or central glucopri-
vation (Kim et al., 2004b; Lee et al., 2005; Minokoshi et al., 2004).
Stimulation of AMPK in the ventral hypothalamus increases
endogenous glucose production (McCrimmon et al., 2004),
whereas the latter is suppressed by inhibition of hypothalamic
AMPK (Stoppa et al., 2008; Yang et al., 2010). AMPK participates
in hypoglycemia sensing by promoting the release of counter-
regulatory hormones such as adrenaline and glucagon, stimu-
lating hepatic glucose production (McCrimmon et al., 2008).
This is consistent with the reported stimulation of adrenal sym-
pathetic nerve activity upon intracerebroventricular injection of
AMPK activator (Tanida and Yamamoto, 2011).
CnsGlud1/ mice exhibited increased hypothalamic P-AMPK
levels in conditions of normoglycemia and elevated circulating
catecholamines without changes in glucagon or corticosterone.
Catecholamines are known to stimulate hepatic glucose pro-
duction mainly through gluconeogenesis by promoting fuel
mobilization. CnsGlud1/ mice exhibited higher sympathetic
tone, as revealed by the increased firing rates of the sympa-
thetic nerve. In particular, the sympathetic outflow to the liver,
as measured by catecholamine turnover, was increased in
CnsGlud1/ mice. Moreover, lower pancreatic polypeptide
levels indicated that the parasympathetic outflow was lower in
CnsGlud1/mice. Collectively, these results show that a change
in the balance of the autonomous nervous system was instru-
mental in the phenotypic response of genetically suppressed
brain GDH.
Regulation of hepatic glucose production via the SNS ismainly
controlled by two mechanisms: neuronal stimulation of the
neuroendocrine system, such as the release of adrenaline and
glucagon, and direct liver innervation controlling glycogen meta-
bolism (Shimazu, 1987). Vagal activation decreases blood
glucose levels by inhibiting hepatic enzymes involved in gluco-
neogenesis and by activating those promoting glycogen synthe-
sis (Shimazu, 1971), effects abolished by vagotomy (German
et al., 2009; Matsuhisa et al., 2000). Recently, it was shown
that activation of hypothalamic AMPK stimulates the SNS, which
in turn activates hepatic gluconeogenesis and glycogenolysis via
the stimulation of b-adrenergic receptors (Ikegami et al., 2013). It
has also been proposed that the effects of hypothalamic AMPK
on endogenous glucose production are mediated by neurons
located at the dorsal vagal complex (Lam et al., 2010).
Based on our experimental data and the literature, we propose
that a lack of GDH in CNS results in central energy scarcity trans-
lated into AMPK activation in the hypothalamus. This in turn
activates the SNS and inhibits the parasympathetic nervous
system. As a consequence, catecholamines may promote liver
gluconeogenesis. CnsGlud1/ mice exhibit moderate hypo-
glycemia in fasting conditions despite increased endogenous
glucose production. The competing higher brain glucose uptake
observed in knockout mice might contribute to this. Hypoglyce-
mia-induced parasympathetic activity is known to stimulate
glucagon secretion (Berthoud et al., 1990; Patel, 1984). Para-Csympathetic activity triggers the initial counter-regulatory res-
ponse to temper hypoglycemia, whereas at lower glycemic
levels, activation of sympathetic activity is induced (Taborsky
and Mundinger, 2012). The lower parasympathetic tone of
CnsGlud1/ mice could explain their modest glucagon res-
ponse to fasting conditions.
Overall, we observed that ablation of GDH in the CNS impaired
oxidative metabolism of glutamate and increased brain glucose
consumption. CnsGlud1/ mice exhibited fasting-like brain
energy sensor activation, despite normoglycemia, resulting in
mobilization of energy substrates from the periphery through
changes in the autonomous nervous system balance. This
possible sequence of events will require further work to delineate
the proposed roles for glutamate oxidation in CNS and related
peripheral energy metabolism. The ‘‘energy-on-request’’ mech-
anisms illustrate here to which extent the brain dictates the par-
titioning of energy resources, in accordance with the ‘‘selfish
brain’’ paradigm (Peters et al., 2004). Besides its paramount
importance as a neurotransmitter, our study demonstrates that
glutamate is an important energy substrate for the brain. It also
highlights the key role of brain GDH in this process and in the
fine-tuning of glutamate versus glucose utilization to maintain
energy homeostasis. Altogether, our results show that GDH par-
ticipates in central energy provision, modulating peripheral en-
ergy substrate partitioning.EXPERIMENTAL PROCEDURES
Mice
CnsGlud1/ mice, were generated as previously described (Frigerio et al.,
2012). Animals were maintained on a mixed (C57BL/6J 3 129/Sv) genetic
background to avoid inbred strain-specific phenotypes. As control mice, we
used Glud1lox/lox (Glud1tm1.1Pma, MGI:3835667) littermates in order to optimize
standardization of the genetic background between the two groups. To rule
out the possibility that the Nestin-Cre transgene used in the present study
may have independently contributed to the metabolic phenotype, we studied
in parallel cohorts of mice carrying the Nestin-Cre transgene without floxed
Glud1 and wild-type littermates (Karaca and Maechler, 2014) to investigate
some key metabolic parameters, revealing no effects of Nestin-Cre per se.
Since no gender differences were noticed, data presented here are frommales
aged 11–13 weeks. Mice were maintained in our certified animal facility ac-
cording to procedures that were approved by the animal care and experimen-
tation authorities of the Canton of Geneva.
In Vivo Experiments
Brain metabolites were measured by NMR (1H-MRS). Brain glucose uptake
was evaluated following peripheral administration of [14C]-2-deoxyglucose
(Hartmann Analytic). Energy balance and body composition were assessed
using metabolic cages and EchoMRI. Glucose and pyruvate tolerance tests
were performed upon intraperitoneal injection of D-glucose (1 g/kg) or sodium
pyruvate (2 g/kg) (Sigma-Aldrich) after an overnight fast. Insulin secretion was
tested by in situ pancreatic perfusion and glucose turnover rate by hyperinsu-
linemic-euglycemic clamp. The firing rates of the SNS were measured during
nerve recording experiments. The synthesis inhibition method of Brodie et al.
was used to measure the catecholamines turnover rate (Brodie et al., 1966).
Detailed procedures are given in Supplemental Experimental Procedures.
Determination of Metabolic Parameters
Oxygen consumption was measured on mitochondria isolated from brain and
liver. Blood parameters were determined on samples collected from fed or
overnight-fasting animals. Specific measurements are described in detail in
Supplemental Experimental Procedures.ell Reports 13, 365–375, October 13, 2015 ª2015 The Authors 373
Experiments on Isolated Astrocytes
Primary cultures of astrocytes were prepared from 7-day-old mice as
described previously (Frigerio et al., 2012). Cellular ATP levels were measured
in astrocytes transduced either with AdCAG-Luc adenovirus expressing the
ATP-sensitive fluorescent probe luciferase or with ATeamadenovirus express-
ing the fluorescence resonance energy transfer (FRET)-based ATP indicator.
The 13C-labeling pattern in glutamate from incubation with [U-13C]glucose
was analyzed using gas chromatography mass spectrometry and the total
amount of glutamate by high-performance liquid chromatography. Detailed
protocols are given in Supplemental Experimental Procedures.
Expression Analyses by qRT-PCR, Immunoblotting, and
Immunohistochemistry
Quantitative RT-PCRwas performed on total RNA extracts. Antibodies against
phospho-AMPKa (Thr172) (2531, Cell Signaling) and AMPKa (2532, Cell
Signaling), were used for immunoblotting experiments onwhole hypothalamus
extracts. For immunohistochemistry, paraffin sections were stained using an-
tibodies against insulin (I2018, Sigma-Aldrich) and glucagon (G2654, Sigma-
Aldrich). Detailed protocols are described in Supplemental Experimental
Procedures.
Statistics
Data are presented as means ± SEM. Statistical analyses were performed, us-
ing GraphPad Prism 6 software, with one-way ANOVA when more than two
groups of data were compared, with two-way ANOVA when two conditions
were involved, and with Student’s t test when only two groups of data
were concerned. We deemed the difference to be statistically significant
when p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.09.003.
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